News for Agilent Technologies, Inc. (A1GI34.SA)

Summary Agilent Technologies Inc (A) announced that its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR certification as a Companion Diagno

Agilent Technologies Inc. (A) has achieved a significant milestone with the European IVDR certification of its PD-L1 IHC 22C3 pharmDx assay. This certification

Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2025 after the stock market closes on Wednesday, May 2

\n Agilent Technologies (A) to release Q2 2025 financial results on May 28. Conference call scheduled for 1:30 p.m. PDT on the same day. Earnings call r

Bernstein has revised its price target for Agilent Technologies (A), reducing it from $145 to $125. The firm maintains a Market Perform rating for Agilent's sha

BofA has revised its outlook on Agilent Technologies (A), reducing the price target from $156 to $128 while maintaining a Neutral rating on the stock. The adjus

Agilent Technologies, Inc. (A) has announced the resignation of Heidi Kunz from its Board of Directors, effective May 21, 2025. Ms. Kunz, who also served on t

We recently published the Best Retirement Portfolio for a 65-Year-Old. In this article, we are going to take a look at where Agilent Technologies, Inc.

The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing down industry growth.

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Agilent Technologies, Inc.

Summary Agilent Technologies Inc (A) has announced its participation in the United States and Canadian Academy of Pathology (USCAP) Conference, scheduled for Ma

Summary Agilent Technologies Inc (A) has announced its participation in the United States and Canadian Academy of Pathology (USCAP) Conference, scheduled for Ma

Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWC

[url="]Agilent Technologies Inc.[/url] (NYSE: A) today announced that [url="]Columbia University[/url] has received an Agilent Research Catalyst (ARC) Award on

Agilent Technologies (A) recently held its Annual Meeting of Stockholders on March 13, 2025. The meeting saw a significant turnout, with 251,572,214 shares of

[url="]Agilent Technologies Inc.[/url] (NYSE: A) today announced its [url="]PD-L1 IHC 28-8 pharmDx[/url] kit has received two new companion diagnostic indicati

Agilent Technologies, Inc. (NYSE:A) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ETCompany ParticipantsPadraig McDonnell - Chief...

Agilent Technologies Inc's restructuring aligns with market-focused, customer-centric strategy.Revenue growth in Life Sciences and Diagnostics Markets segment

Agilent Technologies, Inc. (A) has announced a significant reorganization of its business segments to better align with its market-focused and customer-centri